Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: enzalutamide|DRUG: anastrozole|DRUG: exemestane|DRUG: fulvestrant|DRUG: enzalutamide|DRUG: exemestane
Sponsor: Pfizer
Collaborators: Astellas Pharma Inc|Medivation LLC, a wholly owned subsidiary of Pfizer Inc.